Terbutaline

Terbutaline, a short-acting beta-agonist (SABA), would not be an appropriate choice for this situation. Amy is already using formoterol, a LABA with both rapid onset and long duration, for symptom relief. Adding a SABA like terbutaline would duplicate her bronchodilator therapy without addressing the underlying cause of her worsening asthma. Treating Amy’s symptoms requires targeting her specific triggers (exercise-induced asthma, atopy), which terbutaline would fail to achieve. Let’s try again!